Cargando…
New under the sun: ClotPro's ECA-test detects hyperfibrinolysis in a higher number of patients, more frequently and 9 min earlier
Liver diseases result in a re-balanced state of the haemostatic system with decreased haemostatic reserves. Increased fibrinolytic activity is commonly seen during liver transplants. The aim of this study was to assess whether ClotPro's ECA-test is able to detect hyperfibrinolysis earlier and w...
Autores principales: | Zátroch, István, Dinya, Elek, Fazakas, János |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894133/ https://www.ncbi.nlm.nih.gov/pubmed/36519572 http://dx.doi.org/10.1097/MBC.0000000000001185 |
Ejemplares similares
-
Monitoring the Coagulation Profile of COVID-19 Patients Using Standard and ClotPro(®) Hemostasis Tests
por: Milić, Dragan, et al.
Publicado: (2023) -
A comparison of the ClotPro system with rotational thromboelastometry in cardiac surgery: a prospective observational study
por: Yoshii, Ryogo, et al.
Publicado: (2022) -
Impact of Idarucizumab and Andexanet Alfa on DOAC Plasma Concentration and ClotPro(®) Clotting Time: An Ex Vivo Spiking Study in A Cohort of Trauma Patients
por: Oberladstätter, Daniel, et al.
Publicado: (2021) -
Effect of Dabigatran on Clotting Time in the Clotpro Ecarin Clotting
Assay: A Prospective, Single-Arm, Open-Label Study
por: Fong, Alan Yean Yip, et al.
Publicado: (2020) -
Comparison of the New Viscoelastic Coagulation Analyzer ClotPro® With ROTEM® Delta and Conventional Coagulation Tests in Critically Ill Patients With COVID-19
por: Infanger, Lukas, et al.
Publicado: (2021)